Kavitha Goyal

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis

Robert E. Kalb, David Fiorentino, Mark Lebwohl et al. · JAMA Dermatology · 2015 · 372 citations

Medicine, Dermatology, Pharmacotherapy +17

Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Alan Menter, Kim Papp, Melinda Gooderham et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 242 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +17

Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry

David Fiorentino, Vincent Ho, Mark Lebwohl et al. · Journal of the American Academy of Dermatology · 2017 · 157 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Bruce Strober, Melinda Gooderham, E.M.G.J. de Jong et al. · Journal of the American Academy of Dermatology · 2017 · 119 citations · Full text

Medicine, Clinical Sciences, Dermatology +14

Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease‐based registry (PSOLAR)

Alexa B. Kimball, C. Leonardi, Mona Ståhle et al. · British Journal of Dermatology · 2014 · 115 citations · Full text

Public Health, Demography, Dermatology +11